Digestibility and Bioavailability of the Active Components of Erica australis L. Aqueous Extracts and Their Therapeutic Potential as Acetylcholinesterase Inhibitors

Figure 1

HPLC-DAD chromatogram (200–500 nm) of Erica australis aqueous extracts: unknown (1), gossypetin glycoside (2), myricetin 3-O-glucoside (3), myricetin 3-O-rhamnoside (4), quercetin 3-O-rhamnoside (5), kaempferol 3-O-rhamnoside (6), and quercetin acetylrhamnoside (7). The peak at 5.33 min is the result of an overlap of two smaller peaks. These two minority compounds were in amounts below the detection limit of the analysis and therefore could not be identified.